SCHEMBL644478

SCHEMBL644478

CCOc1ccc2oc3ccccc3c(=O)c2c1OCC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.52
MAPT P10636 2/20 0.52
TP53 P04637 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
CYP19A1 P11511 1/20 0.49
CYP11B1 P15538 1/20 0.49
CYP11B2 P19099 1/20 0.49
CYP2A6 P11509 1/20 0.48
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
GLA P06280 1/20 0.47
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
PGAM1 P18669 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ADORA3 P0DMS8 1/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29833663 1.00 MAOA (0.52) MAOAMAPTTP53RXFP1CYP19A1
SCHEMBL29287875 0.86 MAOA (0.52) MAOAMAPTTP53RXFP1CYP19A1
SCHEMBL6893811 0.84 MAOA (0.69) MAOAMAPTTP53RXFP1CYP19A1
SCHEMBL1664326 0.81 ADORA3 (0.70) MAPTTP53RXFP1KDM4EHSD17B10
SCHEMBL3326973 0.79 ALOX15 (0.50) MAOAKDM4EALDH1A1CYP3A4HPGD
SCHEMBL5612997 0.78 MAOA (0.69) MAOAMAPTKDM4EALDH1A1CYP3A4
SCHEMBL30255441 0.78 MAOA (0.69) MAOAMAPTKDM4EALDH1A1CYP3A4
SCHEMBL27677461 0.76 ADORA3 (0.48) MAPTTP53RXFP1KDM4EALDH1A1
SCHEMBL1664325 0.76 KDM4E (0.59) MAOAMAPTTP53RXFP1CYP2A6
SCHEMBL392389 0.74 MAOA (0.70) MAOAMAPTKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2711075-B1 Plasmonic assisted systems and methods for interior energy-activation from an exterior source. IMMUNOLIGHT LLC (US) 2024-05-22 EP claimed
US-11535714-B2 Light-curable siloxane resins for additive manufacturing CARBON, INC. (US) 2022-12-27 US claimed
US-11479628-B2 Shelf stable, low tin concentration, dual cure additive manufacturing resins CARBON, INC. (US) 2022-10-25 US claimed
CN-109641997-B Curable resin composition, fuel cell using the same, and sealing method 三键有限公司 2021-12-28 CN claimed
US-20210353954-A1 INSERTION DEVICES AND SYSTEMS FOR PRODUCTION OF EMITTED LIGHT INTERNAL TO A MEDIUM AND METHODS FOR THEIR USE IMMUNOLIGHT, LLC (US) 2021-11-18 US claimed
US-11173467-B2 Systems and methods for interior energy-activation from an exterior source IMMUNOLIGHT, LLC (US) 2021-11-16 US claimed
US-11165072-B2 Curable resin composition, fuel cell using same, and sealing method using same THREEBOND CO., LTD. (JP) 2021-11-02 US claimed
US-20210179761-A1 SHELF STABLE, LOW TIN CONCENTRATION, DUAL CURE ADDITIVE MANUFACTURING RESINS CARBON INC (US) 2021-06-17 US claimed
US-10815388-B2 Primer compositions for injection molding Henkel IP & Holding GmbH (DE) 2020-10-27 US claimed
US-20200332066-A1 LIGHT-CURABLE SILOXANE RESINS FOR ADDITIVE MANUFACTURING CARBON INC (US) 2020-10-22 US claimed
JP-2002518569-A 2002-06-25 JP claimed
WO-2002046291-A1 MULTI-FUNCTIONAL ALPHA-ALKOXYALKYL ACRYLATE AND METHACRYLATE ESTER COMPOSITIONS AND REWORKABLE POLYMERS FORMED THEREFROM HENKEL LOCTITE CORPORATION (US) 2002-06-13 WO claimed
EP-1090061-A4 DUAL CURING SILICONE COMPOSITIONS LOCTITE CORP (US) 2002-01-30 EP claimed
EP-1090061-A1 DUAL CURING SILICONE COMPOSITIONS LOCTITE CORPORATION (US) 2001-04-11 EP claimed
WO-1999067318-A1 DUAL CURING SILICONE COMPOSITIONS LOCTITE CORPORATION (US) 1999-12-29 WO claimed
EP-0397742-A4 POROUS ARTICLE IMPREGNATION RESIN COMPOSITION, AND SYSTEM FOR TREATING IMPREGNATION PROCESS WASTE WATER 1991-07-03 EP claimed
EP-0397742-A1 POROUS ARTICLE IMPREGNATION RESIN COMPOSITION, AND SYSTEM FOR TREATING IMPREGNATION PROCESS WASTE WATER. LOCTITE CORP (US) 1990-11-22 EP claimed
WO-1989006245-A1 POROUS ARTICLE IMPREGNATION RESIN COMPOSITION, AND SYSTEM FOR TREATING IMPREGNATION PROCESS WASTE WATER LOCTITE CORPORATION (US) 1989-07-13 WO claimed
US-4239077-A ULTRAVIOLET RADIATION SENSITIVE PHOTOINITIATOR AND A POLYMERIZABLE MONOMER ON A PAPER SHEET WESTINGHOUSE ELECTRIC CORP. (US) 1980-12-16 US claimed
EP-0012542-A1 Method of making heat curable adhesive coated insulation for transformers WESTINGHOUSE ELECTRIC CORPORATION (US) 1980-06-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353954-A1 INSERTION DEVICES AND SYSTEMS FOR PRODUCTION OF EMITTED LIGHT INTERNAL TO A MEDIUM AND METHODS FOR THEIR USE NEFM, PIGS, GHITM MAOA 540/4885MAPT 303/4885TP53 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.